Topic - Johnson & Johnson

Related Stories



"Data continue to support a favorable benefit-risk profile for the Johnson & Johnson COVID-19 vaccine in adults when compared with no vaccine," the company said.

FDA moves to curtail use of the J&J COVID-19 vaccine →

In response to a proposed audit of its anti-racism training and hiring policies, Johnson & Johnson’s board said in a proxy statement: “Diversity, equity and inclusion (DEI) is built into Our Credo and has long been a core value of the Company.”

Conservatives rack up wins against 'woke' corporations →

© Copyright 2022 The Washington Times, LLC
3600 New York Avenue NE, Washington, DC 20002

Switch to Desktop version